Risk stratified monitoring for methotrexate toxicity in immune mediated inflammatory diseases: prognostic model development and validation using primary care data from the UK

Author
G. Nakafero
M. Grainge
H. Williams
T. Card
M. Taal
G. Aithal
C. Fox
C. Mallen
D. van der Windt
M. Stevenson
R. Riley
A. Abhishek
Keywords
Adult
Humans
Prognosis
*Methotrexate/adverse effects
Retrospective Studies
*Drug-Related Side Effects and Adverse Reactions
Primary health care
United Kingdom/epidemiology
Year of Publication
2023
Journal
Bmj
Volume
381
Number of Pages
e074678
ISBN Number
0959-8138 (Print)
0959-8138
Accession Number
37253479
DOI
10.1136/bmj-2022-074678